CHF6366
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CHF6366, covering 2020-05-07 to 2020-05-07. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Dose in Healthy Volunteers, Repeat Doses in Asthmatic Patients and of Single Dose in COPD Patients of CHF6366 [Phase 1, Phase 2]